RSS

Issue 7

A developer of transdermal drug delivery treatments for pain and central nervous systems diseases has been awarded a Medicines Manufacturing Grant by Innovate UK. Read more

News

An old antibiotic could be the key to killing off dangerous skin cancer cells, new research shows. Read more

News

The October issue of @EPM_magazine is available for download with all the regulars and features on tablet formulation, drug delivery, lab automation and clinical trials. Read more

Latest Issue

Healthcare group Novartis will cut 2,000 jobs around the world in response to a changing product portfolio, the company has announced. Read more

News

Dr David Lewis, director of Aerosol Research Chiesi discusses the environmental concerns that come with pressurised metered dose inhalers (pMDIs). Read more

Opinion

Medherant’s Sukhy Nandra, Vasiliki Nikolaou and David Haddleton discuss the benefits and limitations of transdermal drug delivery systems. Read more

, , Opinion

Global CMO Evonik has completed a €36 million expansion of advanced technologies to help boost its manufacturing capabilities across the US and Europe. Read more

News

In this feature of Tech Talk, Dr Neil Polwart, Novarum founder and BBI Group head of mobile discusses how pharmaceutical manufacturers can go digital using only their smartphones. Read more

News

Dale Pittock, Valley Northern, looks at the benefits of using contract packaging services across the pharmaceutical manufacturing sector. Read more

Opinion

New technologies are changing the way pharmaceutical supply chains operate. Here, Marc Herlant, Arthur D. Little, discusses how predictive analytics offers pharmaceutical manufacturers new supply chain capabilities. Read more

Opinion

With the cost of chronic diseases continuing to spiral and patients commonly failing to comply with medication, Chris Evans, West Pharmaceutical Services, explains why connected health could be the answer. Read more

Opinion

Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved. Read more

, Opinion

For all the effort and investment drugs companies have put into improving business agility, the gap between vision and reality is glaring. This could be because companies have yet to transform R&D decision-making, says James Man, Kinapse. Read more

Opinion

Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds. Read more

Opinion

In his first Editor's Desk focus, Reece Armstrong asks whether it's time pharmaceutical manufacturers change their approaches to the way drugs are developed, in response to changing healthcare needs around the world. Read more

Latest Issue

Jonathan Gaik, director, Natoli Scientific, offers a stepwise approach to pharmaceutical manufacturers looking to optimise their tablet formulation strategy. Read more

Latest Issue